Luben M.
- Country
- Bulgaria
- Department
- Clinic of Gastroenterology
Research Overview
Data & Insights
Has run more than one trial at 39 of 81 partner sites.
Specializations
Hepatology Focus
The investigator specializes in the study of non-alcoholic steatohepatitis (NASH), a progressive liver condition. Their research emphasizes therapeutic interventions for advanced liver disease states, particularly in patients with significant hepatic fibrosis.
- Liver Disease Management
- Fibrosis Assessment
- NASH Treatment Innovation
The research explores novel approaches to improving liver histology and reducing liver-related clinical events in NASH patients.
Metabolic Disease Research
The investigator conducts research in metabolic disorders with a particular focus on therapeutic interventions using peptide-based treatments. Their work examines the intersection of metabolic dysfunction and liver health.
- Metabolic Pathway Analysis
- Therapeutic Development
- Clinical Outcomes Assessment
Their studies evaluate innovative therapeutic approaches for managing complex metabolic conditions affecting liver function.
Clinical Assessment Expertise
The investigator specializes in evaluating liver histological improvements and monitoring disease progression in chronic liver conditions. Their work involves comprehensive assessment of treatment outcomes in liver disease.
- Histological Analysis
- Disease Progression Monitoring
- Treatment Response Evaluation
Their research includes long-term monitoring of clinical outcomes in patients with chronic liver conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.